Role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment

The last few years important changes have occurred in the field of diabetes treatment. The priority in the therapy of patients with diabetes is not glycemic control per se rather an overall management of risk factors, while individualization of glycemic target is suggested. Furthermore, regulatory a...

Descripción completa

Detalles Bibliográficos
Autores principales: Florentin, Matilda, Kostapanos, Michael S, Papazafiropoulou, Athanasia K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855136/
https://www.ncbi.nlm.nih.gov/pubmed/35211246
http://dx.doi.org/10.4239/wjd.v13.i2.85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855136/
https://www.ncbi.nlm.nih.gov/pubmed/35211246
http://dx.doi.org/10.4239/wjd.v13.i2.85

Ejemplares similares